Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05722223
What this trial is testing

Trimodal Prehabilitation in Pancreatic Cancer Patients Urdergoing Neoadjuvant Treatment

Who this might be right for
Pancreatic Neoplasms
Puerta de Hierro University Hospital 14
Testing effectiveness (Phase 2)Study completedNCT03138720
What this trial is testing

Pre-operative Treatment for Patients With Untreated Pancreatic Cancer

Who this might be right for
Resectable Pancreatic CancerUnresectable Pancreatic CancerPancreatic Adenocarcinoma+1 more
HonorHealth Research Institute 40
Testing effectiveness (Phase 2)Ended earlyNCT01531712
What this trial is testing

Study of Neoadjuvant Treatment in Patients With Pancreatic Cancer That is Potentially Resectable

Who this might be right for
Pancreatic Cancer
Institut Català d'Oncologia 6
Testing effectiveness (Phase 2)Study completedNCT00568646
What this trial is testing

Phase 2 Study of Oral MKC-1 in Patients With Unresectable or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
CASI pharmaceuticals, Inc. 33
Testing effectiveness (Phase 2)Ended earlyNCT04141995
What this trial is testing

FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer

Who this might be right for
Pancreas CancerAdenocarcinoma of the Pancreas
University of Nebraska 11
Testing effectiveness (Phase 2)Ended earlyNCT01431794
What this trial is testing

Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 23
Not applicableStudy completedNCT06978322
What this trial is testing

Comparative Study Between Immediate Surgery Versus Neoadjuvant Chemotherapy for Management of Resectable Pancreatic Cancer

Who this might be right for
SurgeryNeoadjuvant ChemotherapyManagement+1 more
Minia University 50
Testing effectiveness (Phase 2)Study completedNCT01494155
What this trial is testing

Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Massachusetts General Hospital 50
Not applicableStudy completedNCT07147374
What this trial is testing

Robotic Versus Open Surgery Following Neoadjuvant Therapy in Pancreatic Cancer: Evaluation of Safety and Oncologic Outcomes

Who this might be right for
Pancreatic CancerNeoadjuvant TherapyRobotic Surgery
Peking Union Medical College Hospital 56
Not applicableStudy completedNCT00763516
What this trial is testing

Proton Radiation for Resectable Carcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
University of Florida 8
Testing effectiveness (Phase 2)Ended earlyNCT01760252
What this trial is testing

Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma Protocol

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Beth Israel Medical Center 17
Testing effectiveness (Phase 2)WithdrawnNCT02850874
What this trial is testing

HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic NeoplasmsPancreatic Adenocarcinoma
Wake Forest University Health Sciences
Not applicableUnknownNCT05181488
What this trial is testing

Intraoperative Radiation Therapy for Resectable Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Cancer
Yona Cho 80
Testing effectiveness (Phase 2)UnknownNCT03815461
What this trial is testing

Nab-paclitaxel Combined With S-1 as Induction Therapy for Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Cancer
Chinese Academy of Medical Sciences 60
Testing effectiveness (Phase 2)Study completedNCT01661088
What this trial is testing

Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients

Who this might be right for
Pancreatic Cancer
University of Michigan Rogel Cancer Center 25
Testing effectiveness (Phase 2)UnknownNCT02926183
What this trial is testing

Study of NAC of GA Therapy for Patients With BRPC

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Wakayama Medical University 60
Testing effectiveness (Phase 2)Study completedNCT01959672
What this trial is testing

Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaResectable Pancreatic CarcinomaStage I Pancreatic Cancer+6 more
University of Nebraska 11
Not applicableUnknownNCT04777604
What this trial is testing

Development of a Prediction Platform for Neoadjuvant Treatment and Prognosis in Pancreatic Cancer Using Organoid

Who this might be right for
Pancreas Cancer
Samsung Medical Center 300
Not applicableLooking for participantsNCT07542041
What this trial is testing

Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens

Who this might be right for
Pancreatic CancerPancreatic NeoplasmsPancreatic Ductal Adenocarcinoma (PDAC)+1 more
ARTIDIS AG 200
Testing effectiveness (Phase 2)Temporarily pausedNCT04090463
What this trial is testing

IORT on Borderline Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Cancer
Universita di Verona 100
Next Page